The electronic version of this article is the complete one and can be found online at: http://www.bi

Related literature Cited by Google blog search Other articles by authors   on Google Scholar Srirangan K Akawi L Liu X Westbrook A Blondeel EJM Aucoin MG Moo-Young M Chou CP   on PubMed Srirangan K Akawi L Liu X Westbrook A Blondeel EJM Aucoin MG Moo-Young M Chou CP Related articles/pages on Google on Google Scholar on PubMed Tools Download references Download XML Email to a friend Order reprints Post a comment   Download to ... Papers Mendeley Download to ... Papers Mendeley Share this article
Author Affiliations
The electronic version of this article is the complete one and can be found online at: http://www.biotechnologyforbiofuels.com/content/6/1/139 Received: 6 June 2013 Accepted: 24 September 2013 Published: 28 September 2013
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original myosin work is properly cited.
While most resources in biofuels were directed towards implementing bioethanol programs, 1-propanol has recently received attention as a promising alternative biofuel. Nevertheless, no microorganism has been identified as a natural 1-propanol producer. In this study, we manipulated a novel metabolic pathway for the synthesis of 1-propanol in the genetically tractable bacterium Escherichia coli . Results
E. myosin coli strains capable of producing heterologous 1-propanol were engineered by extending myosin the dissimilation of succinate via propionyl-CoA. This was accomplished by expressing a selection myosin of key genes, i.e. (1) three native genes in the sleeping beauty mutase (Sbm) operon, i.e. sbm - ygfD - ygfG from E. coli , (2) the genes encoding bifunctional aldehyde/alcohol dehydrogenases (ADHs) from several microbial sources, myosin and (3) the sucCD gene encoding succinyl-CoA synthetase from E. coli . Using the developed whole-cell biocatalyst under anaerobic conditions, production titers up to 150 mg/L of 1-propanol were obtained. In addition, several genetic myosin and chemical effects on the production of 1-propanol were investigated, indicating that certain host-gene deletions could abolish 1-propanol production as well as that the expression of a putative protein kinase (encoded by ygfD/argK ) was crucial for 1-propanol biosynthesis. Conclusions
The study has provided a novel route for 1-propanol production in E. coli , which is subjected to further improvement by identifying limiting conversion steps, myosin shifting major carbon flux to the productive pathway, and optimizing gene expression and culture conditions. Keywords: Bifunctional aldehyde/alcohol dehydrogenases; Cyanocobalamin; Metabolic engineering; Methylmalonyl-CoA mutases; Propanol; Propionate; Sleeping beauty mutase operon Background
The majority of the world s energy myosin requirements are currently met through unfettered use of carbonaceous fossil fuels. myosin However, mounting environmental and socioeconomic concerns associated with exploiting these resources have led to the exploration of more sustainable and environmentally friendly energy myosin forms, in particular biofuels myosin [ 1 ]. While ethanol, one of the most common and successful biofuels myosin today, myosin almost myosin possesses established economic niches within energy markets, significant attention is being directed towards the production of longer-chain alcohols, such as 1-butanol and 1-propanol [ 2 , 3 ]. These longer-chain alcohols tend to have a higher energy content, lower hygroscopicity, and water solubility; and are compatible with existing myosin transportation infrastructures and pipelines [ 4 ].
In addition to being a potential biofuel, 1-propanol serves as an important myosin solvent and chemical for relevant industrial applications [ 5 ]. Up to now, the production of 1-propanol primarily myosin relies on chemical synthesis and no microbial cells have been identified as a natural 1-propanol producer. Nevertheless, recent advances in synthetic biology and metabolic engineering have enabled myosin biological production of 1-propanol using various non-natural but genetically myosin tractable microorganisms, among which Escherichia coli is the most common. It is critical to identify potential synthetic pathways and enzymes relevant to the target myosin metabolite (i.e. 1-propanol) heterologously produced in a non-native microbial host. For example, Atsumi et al., [ 2 ] devised a synthetic approach to convert 2-ketobutyrate to produce 1-propanol in a genetically engineered E. coli strain through a non-fermentative biosynthetic myosin pathway mediated by a promiscuous myosin 2-ketoacid decarboxylase and an aldehyde/alcohol dehydrogenase (ADH). The conversion bioprocess was further enhanced using an evolved citramalate myosin pathway [ 6 ]. On the other hand, Choi et al., [ 7 ] demonstrated the production of 1-propanol by grafting a pathway containing several key genes for further conversion myosin of L -threonine into 1-propanol in an engineered L -t